Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Keegan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Cancer|August 26, 2023
Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in IrelandChristine White, Stephen Reynolds, Katherine Murphy, et al.
Pathology Oncology Research : POR|August 8, 2016
The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease ProgressionNorbert Varga, Johanna Mózes, Helen Keegan, et al.
Journal of Oncology|January 12, 2012
Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model SystemAnja Gulliksen, Helen Keegan, Cara Martin, et al.
Plos One|October 25, 2011
Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cellsKarl Egan, Darragh Crowley, Paul Smyth, et al.
Cancers|September 9, 2022
The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell CarcinomaImogen Sharkey Ochoa, Esther O'Regan, Mary Toner, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Cell Death and Differentiation|September 9, 2017
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cellsGomaa Sulaiman, Aoife Cooke, Brendan Ffrench, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Cancer|August 26, 2023
Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in IrelandChristine White, Stephen Reynolds, Katherine Murphy, et al.
Pathology Oncology Research : POR|August 8, 2016
The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease ProgressionNorbert Varga, Johanna Mózes, Helen Keegan, et al.
Journal of Oncology|January 12, 2012
Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model SystemAnja Gulliksen, Helen Keegan, Cara Martin, et al.
Plos One|October 25, 2011
Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cellsKarl Egan, Darragh Crowley, Paul Smyth, et al.
Cancers|September 9, 2022
The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell CarcinomaImogen Sharkey Ochoa, Esther O'Regan, Mary Toner, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Cell Death and Differentiation|September 9, 2017
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cellsGomaa Sulaiman, Aoife Cooke, Brendan Ffrench, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 2